# Orreco

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/orreco

- Industry: Software
- Headquarters: Galway, Ireland
- Website: www.orreco.com
- Total disclosed funding: $11M
- Latest round: Series A (Dec 4, 2025)
- Investors on record: 5

## About

Orreco Limited provides advanced bio-analytics and performance optimization solutions designed for elite athletes and sports teams, focusing on personalized training and recovery strategies based on scientific research.Founded in 2010 by its CEO Brian Moore and Andrew Hodgson and headquartered in Galway, Ireland, Orreco Limited specializes in data-driven performance optimization for athletes. In December 2025, Orreco Limited raised USD 4 million in a series A extension round from Enterprise Ireland,  True Ventures and 20VC. The round was part of larger? USD 7.5 series A round.Orreco specializes in delivering advanced bio-analytics and data-driven performance optimization solutions tailored to elite athletes and sports teams. The company's core offerings include personalized training, nutrition, and recovery strategies, grounded in extensive peer-reviewed research conducted by their in-house team of sports and data scientists. Key products encompass a software platform that utilizes physiology and biostatistics, offering instant individualized insights derived from blood tests that analyze over 50 biomarkers. Orreco has developed specific programs, such as the Female Athlete Program, aimed at revolutionizing the preparation and performance of female athletes, serving a diverse clientele across professional sports organizations and teams in North America, Europe, and Asia. The company operates on a subscription-based model, engaging clients in ongoing collaborations for access to their suite of products and services, which include bio-analytics services and personalized athletic performance strategies, all structured through contractual agreements. The pricing plans are tiered, enabling clients to select services tailored to their performance goals, promoting sustained engagement and value creation.The company plans to use the December 2025 funding to support the further development of its AI-powered motion signal technology to track athlete movements.

## Funding rounds

- Series A, Dec 4, 2025, $4M — True Ventures, 20VC, Enterprise Ireland
- Series B, Jan 19, 2021, $3.6M — True Ventures, LAUNCH
- Series A, Apr 10, 2019, $1.5M — True Ventures
- Series A, Feb 15, 2017, $2M — True Ventures, Teneo Holdings LLC

## Investors

- True Ventures (https://capitalatlas.ai/funds/true-ventures) — Series A, Series B
- Teneo Holdings LLC — Series A
- LAUNCH (https://capitalatlas.ai/funds/launch) — Series B
- 20VC (https://capitalatlas.ai/funds/20vc) — Series A
- Enterprise Ireland (https://capitalatlas.ai/funds/enterprise-ireland) — Series A